These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 21843059)
1. Bevacizumab pharmacogenetics in tumor treatment: still looking for the right pieces of the puzzle. Bocci G; Loupakis F Pharmacogenomics; 2011 Aug; 12(8):1077-80. PubMed ID: 21843059 [No Abstract] [Full Text] [Related]
2. Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies. Grothey A; Ellis LM Cancer J; 2008; 14(3):170-7. PubMed ID: 18536556 [TBL] [Abstract][Full Text] [Related]
3. A new weapon for attacking tumor blood vessels. Semenza GL N Engl J Med; 2008 May; 358(19):2066-7. PubMed ID: 18463385 [No Abstract] [Full Text] [Related]
4. [New medications; bevacizumab]. Cohen AF; van Bronswijk H Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2194-5. PubMed ID: 17061430 [TBL] [Abstract][Full Text] [Related]
5. Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors. Wong H; Yau T; Man CW; Epstein RJ Acta Oncol; 2009; 48(8):1213-5. PubMed ID: 19863234 [No Abstract] [Full Text] [Related]
11. [Inhibition of angiogenesis by proteins, peptides and "small molecules"]. Jayson G; Armand JP; Berdel WE Onkologie; 2005 Oct; 28 Suppl 4():29-34. PubMed ID: 16205103 [No Abstract] [Full Text] [Related]
12. Bevacizumab in the treatment of breast cancer. Koutras AK; Fountzilas G; Makatsoris T; Peroukides S; Kalofonos HP Cancer Treat Rev; 2010 Feb; 36(1):75-82. PubMed ID: 19932567 [TBL] [Abstract][Full Text] [Related]
13. [Role of angiogenesis inhibitors in the treatment of colorectal cancer]. Bodoky G Magy Onkol; 2007; 51(2):139-44. PubMed ID: 17660870 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity. dell'Omo R; Kulkarni A; Franks WA Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905 [No Abstract] [Full Text] [Related]
15. [Advances of VEGF related molecular promoting tumor angiogenesis and targeting therapy]. Guo ZY; Cao BL Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):282-4. PubMed ID: 20654135 [No Abstract] [Full Text] [Related]
16. [Anti-angiogenesis treatment for brain tumors: present and future]. Takano S; Matsumura A No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703 [No Abstract] [Full Text] [Related]
17. The role of vascular endothelial growth factor genetic variability in cancer. Schneider BP; Radovich M; Miller KD Clin Cancer Res; 2009 Sep; 15(17):5297-302. PubMed ID: 19706811 [TBL] [Abstract][Full Text] [Related]
18. Vascular normalization: study examines how antiangiogenesis therapies work. Webb T J Natl Cancer Inst; 2005 Mar; 97(5):336-7. PubMed ID: 15741568 [No Abstract] [Full Text] [Related]
19. Angiogenesis - still a worthwhile target for breast cancer therapy? Lord S; Harris AL Breast Cancer Res; 2010 Dec; 12 Suppl 4(Suppl 4):S19. PubMed ID: 21172081 [No Abstract] [Full Text] [Related]